List of Trelstar drug patents

Trelstar is owned by Verity.

Trelstar contains Triptorelin Pamoate.

Trelstar has a total of 1 drug patent out of which 0 drug patents have expired.

Trelstar was authorised for market use on 10 March, 2010.

Trelstar is available in injectable;intramuscular dosage forms.

The generics of Trelstar are possible to be released after 30 June, 2029.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10166181 VERITY Slow release pharmaceutical composition made of microgranules
Jun, 2029

(6 years from now)

Drugs and Companies using TRIPTORELIN PAMOATE ingredient

Market Authorisation Date: 10 March, 2010

Treatment: NA

Dosage: INJECTABLE;INTRAMUSCULAR

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in